No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
REGN241227C695000
- 17.70
- -27.40-60.75%
15min DelayClose Dec 20 16:00 ET
17.70High17.70Low
17.70Open45.10Pre Close2 Volume1 Open Interest695.00Strike Price3.54KTurnover32.53%IV1.55%PremiumDec 27, 2024Expiry Date6.85Intrinsic Value100Multiplier4DDays to Expiry10.85Extrinsic Value100Contract SizeAmericanOptions Type0.6199Delta0.0151Gamma49.95Leverage Ratio-1.1889Theta0.0516Rho30.97Eff Leverage0.2958Vega
Intraday
- 5D
- Daily
News
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
CCORF Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,152
Jefferies Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,200
TD Cowen Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,230
BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $950 From $1,190, Keeps Outperform Rating